- Case report
- Open Access
IgG4-related systemic disease mimicking renal pelvic cancer: a rare case
© Wang et al.; licensee BioMed Central. 2014
- Received: 27 August 2014
- Accepted: 3 December 2014
- Published: 23 December 2014
Immunoglobulin G4–related disease (IgG4-RD) is a new clinical entity. Characteristic features of IgG4-RD are elevated serum IgG4 levels, infiltration of IgG4-positive cells, mass-forming lesions with fibrosis and good response to corticosteroids. The variable imaging features of IgG4-RD and the overlap with other differential diagnoses often pose a diagnostic challenge, as they frequently mimic malignant tumors or other inflammatory diseases in the abdomen.
A 54-year-old woman visited our hospital with left flank discomfort and palpebral edema. Computed tomography, magnetic resonance imaging, retrograde pyelography and positron emission tomography/computed tomography indicated renal pelvic cancer. However, after a left-sided nephroureteral cystectomy was performed, the mass was pathologically confirmed as an IgG4-related lesion. Her elevated serum IgG4 level and a past history of sicca complex supported the diagnosis of IgG4-RD.
It is critical to recognize the importance of laboratory examinations such as serum IgG4 level if a patient has a past history of rheumatic disease.
- Mikulicz’s disease
- Renal pelvic cancer
Immunoglobulin G4–related disease (IgG4-RD) is a new clinical entity. Characteristic features of IgG4-RD are elevated serum IgG4 levels, infiltration of IgG4 positive cells, mass-forming lesions with fibrosis and good response to corticosteroids. Variable imaging features of IgG4-RD and the overlap with other differential diagnoses often pose a diagnostic challenge, as they frequently mimic malignant tumors or other inflammatory diseases in the abdomen.
After the diagnosis of IgG4-RD was made, a further laboratory examination was performed. The patient’s serum IgG4 level was 18.6 g/L (normal reference range, 0.03 to 2 g/L), and her high-sensitivity C-reactive protein test result was 26.3 mg/L (normal reference range, 0 to 3 mg/L). The patient underwent steroid therapy in a local hospital for 1 year. At the fourth month of her steroid therapy, her high-sensitivity C-reactive protein level had descended to 8.76 mg/L (normal reference range, 0 to 8 mg/L). Her enlarged lymph nodes in the supraclavicular, retroperitoneal, peritoneal and pelvic regions diminished with the steroid therapy.
IgG4-RD is a relatively new clinical entity proposed by authors from Japan. Characteristic features of IgG4-RD are elevated serum IgG4 level, infiltration of IgG4 positive cells, mass-forming lesions with fibrosis and good response to corticosteroids.
The variable imaging features of IgG4-RD and the overlap with other differential diagnoses often pose a diagnostic challenge, as they frequently mimic malignant tumors or other inflammatory diseases in the abdomen. Renal lesions in IgG4-RD most commonly manifest as multiple wedge-shaped or nodular cortical lesions in one or both kidneys. These lesions are of low intensity in the early phase of postcontrast CT or MRI scans and become less distinct in the late phase of enhancement. The lesions are typically hypointense on T2-weighted MRI scans. Hematuria may often be observed[2, 4].
IgG4-related renal lesions can mimic renal cell carcinoma or transitional cell carcinoma in uncommon cases of a single unilateral mass, such as a renal lesion or focal unilateral renal pelvic wall thickening. Yoshino et al. reported a case of IgG4-related retroperitoneal fibrosis mimicking renal pelvic cancer. CT revealed left hydronephrosis and a thick retroperitoneal soft tissue mass around the ureteropelvic junction, raising suspicion of renal pelvic cancer. Their patient refused tumor biopsy. Therefore, he was treated with corticosteroid therapy on the basis of a clinical diagnosis of IgG4-related retroperitoneal fibrosis. Regression of the retroperitoneal mass and a decrease in serum IgG4 levels were observed.
In our present case, all the imaging findings, including CT, MRI and retrograde pyelography, strongly indicated that the mass was a malignant one. On the basis of our experience in the present case, we do not believe PET/CT is a reliable way to differentiate IgG4-RD from renal malignancy. The renal pelvic mass in our patient was observed to be hypermetabolic on a PET scan. Multiple lymph nodes in the supraclavicular, retroperitoneal, peritoneal and pelvic regions were enlarged and hypermetabolic, vividly mimicking lymph nodes metastasis. We may draw a conclusion that a tumor biopsy should be done for patients with renal pelvic masses, even in cases with confirmed IgG4-RD, on the basis of the fact that the standardized incidence ratio for cancers in patients with IgG4-RD has been reported to be approximately 3.5 times higher than the incidence of cancer in the general population.
Uehara et al. reported a case of a 66-year-old man with IgG4-RD in whom they performed an autopsy. The patient had been diagnosed with Mikulicz’s disease and an IgG4-related pseudoinflammatory tumor in the pelvis, but the autopsy disclosed the coexistence of diffuse, large B cell lymphoma. Yoshino et al. also reported a case of IgG4-RD mimicking renal pelvic cancer. CT in their patient raised suspicions of renal pelvic cancer. Their patient’s serum levels of IgG and IgG4 were found to be elevated in laboratory tests. They treated the patient with corticosteroid therapy. Regression of the retroperitoneal mass and improvement of left hydronephrosis were achieved. Our patient responded to corticosteroid therapy, too, with a decline in high-sensitivity C-reactive protein and diminishment of enlarged lymph nodes. Because conservative treatments have remarkable effect in this kind of disease, it is vital to avoid unnecessary surgery. CT-guided biopsy or laparoscopic biopsy of the original tumor or lymph node swelling might help to rule out malignancy.
The past medical history is another important clue in the differentiation of IgG4-RD from renal pelvic malignancy. The salivary gland is one of the target organs in IgG4-RD, and the clinical phenotype is so-called Mikulicz’s disease. In the present case, our patient’s history of sicca complex did not draw much attention, because the imaging findings strongly indicated a malignant tumor.
In patients such as the one we describe in this report, it is critical to recognize the importance of laboratory examinations such as serum IgG4 level if a patient has a past history of rheumatic disease.
Written informed consent was obtained from the patient for the publication of this report and any accompanying images.
This work was funded by Scientific Research Projects of Shanghai under Shanghai Science and Technology Commission grant 14ZR1406300. This case report was prepared in accordance with the ethical standards of Fudan University.
- Yamamoto M, Takahashi H, Ohara M, Suzuki C, Naishiro Y, Yamamoto H, Shinomura Y, Imai K: A new conceptualization for Mikulicz’s disease as an IgG4-related plasmacytic disease. Mod Rheumatol. 2006, 16: 335-340. 10.3109/s10165-006-0518-Y.PubMed CentralView ArticlePubMedGoogle Scholar
- Al Zahrani H, Kim TK, Khalili K, Vlachou P, Yu H, Jang HJ: IgG4-related disease in the abdomen: a great mimicker. Semin Ultrasound CT MR. 2014, 35: 240-254. 10.1053/j.sult.2013.12.002.View ArticlePubMedGoogle Scholar
- Khalili K, Doyle DJ, Chawla TP, Hanbidge AE: Renal cortical lesions in patients with autoimmune pancreatitis: a clue to differentiation from pancreatic malignancy. Eur J Radiol. 2008, 67: 329-335. 10.1016/j.ejrad.2007.07.020.View ArticlePubMedGoogle Scholar
- Saeki T, Nishi S, Ito T, Yamazaki H, Miyamura S, Emura I, Imai N, Ueno M, Saito A, Gejyo F: Renal lesions in IgG4-related systemic disease. Intern Med. 2007, 46: 1365-1371. 10.2169/internalmedicine.46.0183.View ArticlePubMedGoogle Scholar
- Yoshino T, Moriyama H, Fukushima M, Sanda N: A case of IgG4-related retroperitoneal fibrosis mimicking renal pelvic cancer. Urol Int. 2013, 90: 365-368. 10.1159/000341703.View ArticlePubMedGoogle Scholar
- Yamamoto M, Takahashi H, Tabeya T, Suzuki C, Naishiro Y, Ishigami K, Yajima H, Shimizu Y, Obara M, Yamamoto H, Himi T, Imai K, Shinomura Y: Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012, 22: 414-418. 10.3109/s10165-011-0520-x.View ArticlePubMedGoogle Scholar
- Uehara T, Ikeda S, Hamano H, Kawa S, Moteki H, Matsuda K, Kaneko Y, Hara E: A case of Mikulicz’s disease complicated by malignant lymphoma: a postmortem histopathological finding. Intern Med. 2012, 51: 419-423. 10.2169/internalmedicine.51.5713.View ArticlePubMedGoogle Scholar
- Yamamoto M, Takahashi H, Sugai S, Imai K: Clinical and pathological characteristics of Mikulicz’s disease (IgG4-related plasmacytic exocrinopathy). Autoimmun Rev. 2005, 4: 195-200. 10.1016/j.autrev.2004.10.005.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.